Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

2017 Advances in Drug Discovery and Development - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Advances in Drug Discovery and Development" report has been added to Research and Markets' offering.

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across research advances in gene editing technologies that have enabled enhanced drug screening and target discovery. Furthermore, the service also includes regulatory advances for 3,4-methlyenedioxymethamaphetamine and Ibrutinib therapies. Interestingly, the TOE encompasses advances in novel target discovery for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD). Lastly, the TOE summarizes key technologies and trends fueling the growing use of Big Data for drug discovery applications.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

  1. High-throughput Knock-out Screens Speeding Up Target Discovery
  2. Deleting Tumor Genes Using CRISPR-Cas9 Gene Editing Technology
  3. Virus-like Particles Increasing Lentivirus Transduction for Drug Screening
  4. Addressing Novel Targets for Genetically Defined Cancers
  5. Breakthrough Therapy Designation for Ecstasy Drug
  6. First FDA-Approved Therapy for the Treatment of Chronic Graft Versus Host Disease
  7. New Therapeutic Target Discovered for Chronic Neurodegenerative Diseases
  8. Drug Discovery Technology Focus and Trends
  9. Technology Focus and Trends
  10. Three Start-up Companies to Watch
  11. Industry Interactions

For more information about this report visit https://www.researchandmarkets.com/research/bd8cj9/advances_in_drug

View source version on businesswire.com: http://www.businesswire.com/news/home/20170925005927/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.